Headline
The latest stories from AHA Today.
In part two in a series of podcasts on rebuilding maternity services at a critical access hospital, officials from the UNC School of Medicine at Chapel Hill and Chatham Hospital UNC Health Care at Siler City, N.C., discuss how a plan was fulfilled to reintroduce safe and sustainable maternity…
Seven in 10 U.S. adults who are parents and/or care for an adult with a health condition or who is at risk for COVID-19 reported at least one recent adverse mental health symptom when surveyed between December 2020 and March 2021, the Centers for Disease Control and Prevention reported.
The AHA joined the U.S. Chamber of Commerce and other national organizations in urging the 9th Circuit Court of Appeals to affirm a district court decision that found the Public Readiness and Emergency Preparedness Act of 2005 provides broad immunity from tort liability to health care providers and…
The AHA released the next People Matter, Words Matter poster. The latest downloadable poster focuses on the commonness of mental health conditions and diagnoses, because knowing the facts is one of the best ways to reduce stigma.
The Centers for Disease Control and Prevention updated requirements for health care providers participating in the COVID-19 Vaccination Program to clarify that participants may not sell or divert COVID-19 vaccine or ancillary materials purchased for the program; reproduce the program’s COVID-19…
The United States Supreme Court rejected the third major challenge to the Affordable Care Act, holding in a 7-2 decision that the challengers did not have “standing,” or the legal right to challenge the portions of the ACA they alleged were unconstitutional.
On this AHA Advancing Health podcast, Leon Caldwell, AHA’s senior director of health equity strategies and innovation, talks with Keith Ellison, program director of the Urban League of Philadelphia Entrepreneurship Center, about how the COVID-19 pandemic highlighted the pivotal role local…
A National Institutes of Health-led review of more than 24,000 stored blood samples suggests that the coronavirus that causes COVID-19 was present in the U.S. as far back as December 2019.
The Food and Drug Administration authorized for emergency use one more batch of drug substance manufactured for the Janssen (Johnson & Johnson) COVID-19 vaccine at an Emergent BioSolutions facility in Baltimore.
Rhode Island health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence of the SARS-CoV-2 P.1 and B.1.351 variants, which are not susceptible to the combination therapy, the Department of Health and Human Services’…